Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects
Clinical trial NCT04675021 · COMPLETED
Trial details
- NCT number
- NCT04675021
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2021-01-11
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.